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Abstract 
In this doctoral thesis, a novel method for the determination of primary bile acids cholic acid 
and chenodeoxycholic acid is presented. Bile acids play various vital roles in the mammalian 
body. Moreover, their determination is extremely helpful in liver and biliary disease diagnosis 
and management. These saturated organic compounds lack strong chromophores and 
fluorophores in their structure, and thus are usually hard to detect in spectroscopy. For this 
reason, either instrumentally advanced but expensive methods, such as mass spectrometry, or 
less reliable enzymatic methods are commonly employed in bile acids quantitation. Hence, 
the demand for simple and reliable methods for their determination is strong. Bile acids are 
also known to be virtually inert for direct electrochemical oxidation. Herein, a simple method 
for their chemical activation for electrochemical oxidation on bare electrode materials was 
developed, optimized and applied to cholic acid and chenodeoxycholic acid determination. 
The activation is based on a dehydration reaction of a primary bile acid with 0.1 mol L–1 
HClO4 in acetonitrile (water content 0.55%) that introduces double bond(s) into the originally 
fully saturated steroid core. This naturally increases the electron density in the structure, and 
thus allows electrochemical oxidation of the bile acids under unchanged conditions directly in 
the dehydrating medium at +1.2 V (vs. Ag/AgNO3 in acetonitrile). Increased electrochemical 
activity of cholesterol under equivalent conditions was also observed. The mechanism for the 
activation reaction was proposed based on results of CE-MS experiments. This activation 
reaction was optimized and implemented into an electroanalytical procedure employing 
differential pulse voltammetry on boron-doped diamond electrode, and the bile acids were 
determined in artificial and real-life serum samples with good selectivity. The results of the 
differential pulse voltammetric method were compared to the ones obtained with a previously 
proposed method (HPLC with fluorescence detection) confirming good accuracy of the 
present method. The limits of detection were estimated to be 0.5 µmol L–1 for cholic acid and 
1.0 µmol L–1 for chenodeoxycholic acid. Moreover, application in liquid-flow techniques was 
envisaged. Pilot experiments with flow-injection analysis with amperometric detection in 
wall-jet arrangement using boron-doped diamond working electrode were performed with 
limits of detection of ca 1 µmol L–1 for both compounds, thus confirming favourable potential 
of the method in the amperometric mode of operation. An innovative, simple and fast 
electroanalytical approach to the detection of primary bile acids with a potential of clinical 
application was developed in this doctoral thesis.  
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Abstrakt 
V této dizertační práci byla vyvinuta nová metoda pro stanovení primárních žlučových 
kyselin: cholové kyseliny a chenodeoxycholové kyseliny. V těle savců plní žlučové kyseliny 
rozmanité významné funkce. Jejich stanovení je rovněž důležitým nástrojem v diagnóze 
aléčbě onemocnění jater a žlučníku. Tyto nasycené organické sloučeniny postrádají ve své 
struktuře silné chromofory a fluorofory, což zásadně znesnadňuje jejich spektrometrickou 
detekci. Proto jsou pro účely detekce využívány instrumentálně pokročilé, ale nákladné 
metody, jako je hmotnostní spektrometrie, nebo méně spolehlivé enzymatické metody. 
Z těchto důvodů je neustálá silná poptávka po jednoduchých a spolehlivých metodách 
pro stanovení žlučových kyselin. Je rovněž známo, že žlučové kyseliny je prakticky nemožné 
přímo elektrochemicky oxidovat. V této dizertační práci byla vyvinuta a optimalizována 
metoda, která umožňuje chemickou aktivaci žlučových kyselin pro jejich elektrochemickou 
oxidaci na nemodifikovaných elektrodových materiálech a která byla aplikována pro 
stanovení cholové kyseliny a chenodeoxycholové kyseliny. Tato aktivace je založena na 
dehydratační reakci primární žlučové kyseliny s 0,1 mol l–1 HClO4 v acetonitrilu (obsah vody 
0,55 %), která do původně plně nasyceného steroidního jádra zavede jednu nebo více 
dvojných vazeb. To přirozeně zvýší elektronovou hustotu, a tím umožní elektrochemickou 
oxidaci žlučové kyseliny při +1,2 V (vs. Ag/AgNO3 v acetonitrilu) za nezměněných podmínek 
přímo v dehydratujícím roztoku. Za stejných podmínek byla také pozorována zvýšená 
elektrochemická aktivita cholesterolu. Na základě výsledků CE-MS experimentů byl navržen 
mechanismus této reakce. Aktivační reakce byla optimalizována a implementována 
do elektroanalytického postupu využívajícího diferenční pulsní voltametrii na borem 
dopované diamantové elektrodě a uvedené dvě žlučové kyseliny byly stanoveny ve vzorcích 
umělého a lidského séra s dobrou selektivitou. Výsledky měření za využití diferenční pulsní 
voltametrie byly porovnány s dříve popsanou metodou (HPLC s fluorescenční detekcí), čímž 
byla potvrzena přesnost navržené metody. Byly stanoveny limity detekce: 0,5 µmol l–1 pro 
cholovou kyselinu a 1,0 µmol l–1 pro chenodeoxycholovou kyselinu. Dále byla vyhodnocena 
možnost aplikace tohoto postupu v průtokových metodách. Proběhly pilotní experimenty za 
využití průtokové injekční analýzy s amperometrickou detekcí ve wall-jet uspořádání a s 
borem dopovanou diamantovou elektrodou s limity detekce okolo 1 µmol l–1 analytu, čímž 
byl potvrzen potenciál metody v amperometrickém uspořádání. V této dizertační práci byla 
tedy popsána inovativní, jednoduchá a rychlá elektroanalytická metoda stanovení primárních 
žlučových kyselin s potenciálem pro aplikaci v klinické praxi.  
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1 Aims of the work 
The primary aim of this work was to develop a method for bile acids (BAs) determination 
based on their electrochemical oxidation. Employing a voltammetric or amperometric 
approach for this purpose carries some inherent obstacles that needed to be addressed and 
overcome. Firstly, saturated steroid molecules, such as BAs, possess low intrinsic activity 
towards electrochemical oxidation both in aqueous and non-aqueous media. Moreover, such 
analytes are usually found in complex matrices as blood serum or bile, therefore, the matrix 
can interfere with the determination and its effect needs to be minimized. Overcoming the 
mentioned issues, and the consequent development of a method for BA determination were 
realised in the following steps: 
(i) Review of the up to date literature sources, assessment of possible approaches. 
(ii) Investigation of possibilities of increasing the susceptibility of BAs towards 
electrochemical oxidation. 
(iii) Preliminary investigation of applicability of the developed procedure to related 
steroid compounds such as cholesterol. 
(iv) In-depth characterization and optimization of the analytical process of BAs 
determination. 
(v) Development of a novel electroanalytical method for BAs determination based on 
the established protocol, and its application to biological matrices. 
The results of the work were published in the following journal papers available as 
appendices 6.1 – 6.3: 
1. Klouda J., Barek J., Nesměrák K., Schwarzová-Pecková K.: Non-enzymatic 
Electrochemistry in Characterization and Analysis of Steroid Compounds, Crit. Rev. 
Anal. Chem. 47 (2017) 384–404. Aim (i). 
2. Klouda J., Barek J., Kočovský P., Herl T., Matysik F.M., Nesměrák K., 
Schwarzová-Pecková K., Bile acids: Electrochemical oxidation on bare electrodes after 
acid-induced dehydration, Electrochem. Commun. 86 (2018) 99–103. Aims (ii) and (iii). 
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3. Klouda J., Nesměrák K., Kočovský P., Barek J., Schwarzová-Pecková K., A novel 
voltammetric approach to the detection of primary bile acids in serum samples, 
Bioelectrochemistry 134 (2020) 107539. Aims (iv) and (v). 
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2 Introduction 
The topic was comprehensively reviewed in ref. [1], which is available in appendices as 
Publication I and further highlighted in bold script. 
2.1 Steroids of interest 
In humans, sterols are vital biomolecules with various diverse functions. The main sterol 
biomolecule is cholesterol (Fig. 1). It serves as an essential building block in cell membranes 
[2], and moreover it serves as a precursor for biosynthesis of biomolecules such as bile acids 
[3], or steroid hormones [4]. In the human body, cholesterol is either biosynthesized de novo 
from acetyl coenzyme A by a series of enzyme-assisted reactions heavily regulated at several 
points [5], or it can be absorbed from the diet. A block in cholesterol biosynthesis can lead to 
disease. Smith-Lemli-Opitz syndrome, a congenial malformation disorder, serves as an 
example of such disease. It is caused by a deficient enzyme 7-dehydrocholesterol reductase, 
which catalyzes the last step of cholesterol biosynthesis – reduction of the Δ7,8 double bond in 
7-dehydrocholesterol (7-DHC) [6]. Yet, excessively high levels of cholesterol in plasma can 
be also harmful and may cause a condition known as atherosclerosis. Atherosclerosis is the 
primary cause of heart disease and stroke, and the underlying cause of approximately 50% of 
all deaths in westernized societies [7]. This results in the ever increasing interest in cholesterol 
determination [8]. 
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Fig. 1 Structure of cholesterol with numbered carbon atoms. Analogical numbering is used 
with BAs and other steroids. 
The end-product of cholesterol catabolism, BAs, are amphipathic water-soluble readily 
excreted biomolecules. Based on the number of carbon atoms in their structure C24 and C27 
BAs are discerned [3]. In mammals, C24 BAs are predominant. Most of the physiological, 
pathophysiological and metabolic properties of BAs can be attributed to their detergent-like 
behaviour [9]. Hydroxyl groups in common BAs are oriented in one direction, resulting in a 
concave hydrophilic  face and a convex hydrophobic  face of the molecule, which is devoid 
of the hydrophilic substituents [10]. If the concentration of a BA is sufficient, it will self-
associate to form a micelle (at critical micellar concentration – CMC), presumably due to the 
hydrophobic effect, which aims at minimizing the hydrophobic surface, as well as hydrogen 
binding, which is determined by the number, location and orientation of the hydroxyl groups 
[11]. When the concentration of a BA is below its respective CMC, it is present in monomeric 
form in a solution. Basic physicochemical properties of the studied BAs are summarized in 
Tab. 1. 
In humans, there are two main BAs that are biosynthesized in the liver, termed primary, 
cholic acid (CA) and chenodeoxycholic acid (CDCA) (Fig. 2). As components of bile, they 
are secreted into the gastrointestinal tract, where they can be modified by bacteria. This way, 
predominantly by removal of the hydroxyl group at C7, secondary BAs are formed. Major 
secondary BAs in humans are products of C7 dehydroxylation of CA – deoxycholic acid 
2 Introduction   15 
(DCA); and of CDCA – lithocholic acid (LCA) (Fig. 2) [3,12]. Two most important functions 
of BAs are cholesterol level regulation, and formation of mixed micelles with dietary lipids in 
the small intestine to facilitate digestion of hydrophobic nutrients [13]. Ursodeoxycholic acid 
(UDCA) (Fig. 2) is often used as a medical drug in reduction of biliary cholesterol and 
treatment of diseases such as primary biliary cirrhosis or primary sclerosing cholangitis [14]. 
Moreover, BAs are important regulatory molecules [15], and semi-synthetic BA analogues are 
promising new drug candidates for treatment of chronic liver disease, hepatocellular cancer 
and extrahepatic inflammatory and metabolic diseases due to their intracellular nuclear course 
of action [16]. On one hand, BAs possess antimicrobial properties [17], but on the other, they 
were implicated as co-carcinogens, particularly in cancers of the gastrointestinal tract, due to 
their inherent detergent effect on biological membranes [18]. Importantly, BA levels sharply 
increase in patients suffering from gallstones [19], and a wide range of liver impairments [20–
24]. For all these reasons, knowledge of BAs levels is crucial in the decision-making process 
in clinical practise. 
Tab. 1 Critical micellar concentration, pKa, and water solubility (pH 3, 25 °C) values of the 
studied BAs. Data from [25]. 
Bile acid CMC / mmol L–1 pKa Water solubility / 
µmol L–1 
 Water 0.15 mol L–1 Na+   
CA 13 11 ~5a 273 
CDCA 9 4 ~5a 27 
DCA 10 3 ~5a 28 
LCA n/a  n/a ~5a 0.05 
UDCA 19 7 ~5a 0.9 
aThe ionization properties of the side chain of bile acids is that of isopentanoic acid; the nuclear substituents do 
not influence ionization. 
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Fig. 2 Structures of cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid 
(DCA), lithocholic acid (LCA), and ursodeoxycholic acid (UDCA). 
2.2 Determination of cholesterol and BAs 
Even though determination of both cholesterol and BAs is critical in clinical practise (mainly 
in blood and bile), and cholesterol alone also in food products (predominantly milk and meat 
products), simple methods of their detection are scarce, and/or suffer from setbacks that 
cannot be ignored. This is mainly because analysis and determination of saturated steroid 
compounds (BAs) and steroid compounds containing single double bond (cholesterol) are 
complicated by the absence of strong chromophores or fluorophores. Methods towards the 
analysis of cholesterol [1,8,26,27] and BAs [1,28–31], very often utilizing enzymatic, mass 
spectrometric and/or chromatographic techniques, were reviewed extensively in the past. 
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In food products, cholesterol determination process consists of three fundamental steps: 
saponification, extraction and detection [8]. In routine analyses of food, colorimetric and more 
often chromatographic methods are utilized. In colorimetric determination of cholesterol, 
termed Abell-Kendall method, a chemical reaction between cholesterol and Liebermann-
Burchard reagent (acetic acid, acetic anhydride and sulphuric acid) yields a coloured solution 
[32,33]. More instrumentally advanced methods, such as LC-ID-MS are usually employed in 
quality control. In clinical practise, high-density lipoprotein (HDL) cholesterol and low-
density lipoprotein (LDL) cholesterol is differentiated (amongst others). Treatment decisions 
are based on the concentration levels of LDL cholesterol, considered to be the “bad” 
cholesterol, commonly associated with lesion formation in atherosclerosis [26]. At the same 
time, HDL, the “good” cholesterol, is strongly protective against atherosclerosis as it removes 
the excess cholesterol from peripheral tissues [7]. 
Clinical analysis of BAs is predominantly carried out using enzymatic methods, mostly 
because of the simplicity, high throughput, and the potential for automation. In patients 
suffering from gallstones, the total BA levels can rise by a 42-fold increase (up to a median of 
376.4 µmol L–1) compared to healthy individuals (median 8.87 µmol L–1) [19]. On average, in 
healthy individuals, the total BA values lie in the range between 2.6 and 15.9 µmol L–1. In 
various liver diseases, a 20-fold rise in CA and CDCA (from 2.4 µmol L–1 in healthy 
individuals to 48.9  µmol L–1) has been reported [24]. Advanced analytical methods as GC-
MS and LC-MS are also employed, especially for identification and quantification of 
individual BAs in complex biological matrices and for fundamental research purposes [28–
31]. Conventional LC-MS/MS can be used for studying biochemical processes in the human 
body [34] or in clinical analysis [22]. For BA profiling, UPLC-MS is commonly employed 
[35–38]. Methods that are GC-based or use fluorescence detection (FLD) require 
derivatization procedures: in GC-MS, BAs can be determined as methyl ester-trimethylsilyl 
ether and methyl ester-acetate derivatives [39]. To allow fluorescence detection, BAs have to 
be derivatized with compounds such as 1,2-benzo-3,4-dihydrocarbazole-9-ethyl-p-
toluenesulfonate [40], or 4-nitro-7-N-piperazino-2,1,3-benzoxadiazole [41]. Enzymatic 
methods rely on a reaction between BAs and an enzyme (usually 3α-hydroxysteroid 
dehydrogenase, 3α-HSD). These methods are used to obtain the total serum BA values, as the 
enzymatic oxidation is non-specific. In principle, the enzyme catalysed oxidation of the 3α 
hydroxyl group of the BAs produces NADH (or a corresponding derivative), which can be 
detected by UV or fluorescence spectroscopy. These methods had been used historically [42], 
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and still remain in the spotlight of researchers [43–45]. Very sensitive indirect enzymatic 
electrochemical methods of BAs detection have emerged lately [46,47]. Moreover, ELISA 
methods can be used for the determination of total BAs. In one study, five major components 
of total BAs (CA, CDCA, LCA, DCA and hyodeoxycholic acid) were determined by using an 
indirect competitive ELISA test combining 4 different monoclonal antibodies with the LOD 
of 0.73 µmol L–1 and a relatively narrow linear range of 0.3 to 9.2 µmol L–1. Also, the pursuit 
of simple, fit-for-purpose platforms for determination of CA and CDCA as biomarkers of 
liver disease/damage has been apparent in recent years [21,23,48–51]. There are two different 
approaches used in these studies, however, the fundamental idea is the same. In both 
approaches, BAs interact with a (bio)chemical entity in a defined way, which allows their 
determination using relatively simple and reliable optical methods such as colorimetry [23,51] 
or polarizing microscopy [21,48–50]. In these studies, LODs of 12 µmol L–1 [21], 1 µmol L–1 
[23], 5 µmol L–1 [48], 5 µmol L–1 for CA, and 1 µmol L–1 for CDCA [49], and 20 µmol L–1 
for CA [50] are reported. 
All the above-mentioned methods suffer from various difficulties. In the case of methods 
relying on MS detection, high acquisition and overhead cost is apparent. When derivatization 
is required in GC and fluorescence detection, it proves to be laborious and time-consuming. 
While the above-mentioned, instrumentally advanced, methods possess extremely low LODs 
(generally nanomolar range), and favourably so for research purposes, in clinical analysis 
such low LODs can be regarded unsubstantiated, as the BA levels tend to lie in the tens to 
hundreds micromolar range in most clinical samples. Enzymatic methods based on 3α-HSD 
risk falsely high readings when the enzyme is contaminated with 3β-HSD (cholesterol 
interference), and, moreover, are unable to distinguish between individual BAs. In ELISA, 
risk of cross reactivity is relatively high. Simpler, fit-for-purpose methods deal with different 
hurdles involving selectivity, specificity, stability and applicability to real-life matrices. For 
all these reasons, demand for simple, cheap and reliable methods for BA analysis remains 
strong. 
2.3 Electrochemical oxidation of cholesterol and BAs 
Direct electrochemical oxidation has the potential to meet all the criteria of a reliable BA 
detection method. Electroanalytical methods employing bare electrodes are relatively cheap, 
robust and do not require complicated equipment prone to failure. However, they are not 
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commonly employed for BAs nor cholesterol electroanalysis, owing to the low 
electrochemical activity of these compounds in both positive and negative region. Relative 
merits of non-enzymatic methods in the analysis and characterization of sterol compounds 
were comprehensively reviewed in ref. [1].  
A series of six papers has been published by the group of prof. Kusu on electrochemical 
detection of cholesterol and related compounds [52–57]. They used glassy carbon (GC) and 
boron-doped diamond (BDD) electrodes to oxidize cholesterol and related compounds in non-
aqueous media (mostly acetonitrile/LiClO4) at very high potentials over +1.9 V (vs. 
Ag/AgCl). Moreover, attempts to deeper characterize electrochemical oxidation of cholesterol 
can be traced in the literature [58–60]. Development in cholesterol biosensors based on 
nanomaterials-modified electrodes was reviewed [61]. Such biosensors very often suffer from 
significantly decreased response over days to a couple of months period. 
Indirect method for CA oxidation can be traced in the literature; Medici et al. used PbO2, 
platinum, and graphite electrodes and NaCl as an electron transfer mediator for indirect 
oxidation of CA. Only three studies employing direct oxidation of BAs were found in the 
literature [62–64]. In the first two studies [62,63], HPLC hyphenated with triple-pulsed 
amperometric detection on gold electrode was employed for BA detection. Bile acids are 
essentially aliphatic alcohols, and these molecules are known to be practically 
electrochemically inactive in voltammetry. In contrast to aromatic steroids containing 
hydroxyl group, such as estrone, estradiol or estriol, aliphatic saturated BAs are unable to 
stabilize the radical product of their one-electron oxidation by π-resonance [65]. Therefore, 
BAs cannot be directly oxidized on carbon-based electrode materials. Electrode materials 
with unsaturated valence orbitals (gold, platinum) can stabilize these radicals and are able to 
directly oxidize BAs [62,63]. Nevertheless, this process is accompanied with rapid fouling of 
the electrode surface, thus, pre-treatment pulse (E1), detection pulse (E2) and cleaning pulse 
(E3) have to be applied in a rapid sequence [66], practically ruling out the use of voltammetric 
techniques (E1 = +0.03 V, +0.05 V resp.; E2 = +0.60 V; E3 = –0.80 V, –0.60 V resp. vs. 
Ag/AgCl). In these methods, a relatively narrow linear dynamic range is reported (0.6 to 
14 µmol L–1 [62]). Also, a pH value approaching 13 is required, which limits the use of the 
reversed-phase silica-based columns. The third study employed HPLC with a detector 
consisting of two in-line porous graphite electrodes (+0.60 V and +1.40 V) used for UDCA 
detection [64]. However, the electrochemical process on which the detection is based is not 
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very well characterized in the study; the authors do not state what reference electrode was 
used, and do not provide any basic electrochemical characterization of the process, such as 
CVs of UDCA oxidation. Therefore, thus far, no well-established and characterized methods 
of BAs direct electroanalytical determination exist. As mentioned above, electrode material 
plays a significant role in the electrochemical process of oxidation. It affects the mechanism 
of oxidation, but also the extent of fouling of the electrode, charging current intensity, or the 
width of the potential window. For all these reasons, a great deal of care must be paid to 
choosing the right material for the selected application. 
Boron-doped diamond represents a modern electrode material with superb 
electrochemical and mechanical properties [67–69]. These include the ability to prepare the 
material in various architectures, a wide working potential window, enhanced signal-to-
background ratios due to the low background current, weak molecular adsorption, and optical 
transparency. Weak molecular adsorption, resulting in low proclivity to fouling, is especially 
favourable in electroanalysis. Although modern, the functionality of BDD is very well 
understood and appreciated nowadays [70]. For all the reasons listed above, BDD was 
selected as the main electrode material throughout this work. 
The knowledge summarized in the previous paragraphs served as a stepping-stone for the 
development of a novel and ingenious approach that enables direct electrochemical detection 
of CA and CDCA. 
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3 Results and discussion 
Major parts of this work were published in refs. [71] and [72], which are available in 
appendices as Publication II and Publication III and further highlighted in bold script. 
3.1 Activating steroids for electroanalysis 
Intrinsically, BAs do not show much electrochemical activity in the non-aqueous medium of 
acetonitrile containing 0.1 mol L–1 NaClO4 as a supporting electrolyte (SE), as illustrated in 
Fig. 3A for CA and CDCA. There is only a hint of a peak at high potential over +1.8 V (vs. 
Ag/AgNO3 in acetonitrile) close to the SE decomposition. Voltammetric response so close to 
the SE decomposition is hardly employable in electroanalysis because of the difficulty of peak 
evaluation, and because of the level of interference that is to be expected at highly positive 
potentials. Therefore, a way to increase the electrochemical oxidizability of BAs (i.e., to 
“activate” them) had to be implemented into the analytical procedure. 
 
Fig. 3 Cyclic voltammograms of (a) CDCA and (b) CA (c = 9×10–5 mol L–1) in 0.1 mol L–1 
(A) NaClO4 and (B) HClO4 in acetonitrile. Supporting electrolyte in dashed line. Water 
content (B) 0.550 ± 0.002%. Ambient temperature 21 °C. Scan rate 50 mV s–1. Polished BDD 
electrode (Ageom = 7.07 mm
2). Voltammograms recorded 90 min after the solutions were 
prepared from respective stock solutions. 
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One way to increase the proclivity of an organic compound to electrochemical oxidation 
is to increase the electron density in its structure. That can be achieved by introducing double 
bond(s) in the molecule. In the case of BAs, it can be done by removing one of the hydroxyl 
groups present at the steroid backbone through a dehydration reaction. A well-known 
dehydration reaction that is widely applied to the principal sterol, cholesterol, is the 
aforementioned Liebermann-Burchard reaction. It is the reaction between cholesterol and a 
mixture of acetic acid, acetic anhydride and sulphuric acid used in Abell-Kendall method for 
cholesterol determination to allow its colorimetric detection [32]. It converts the poorly 
absorbing cholesterol molecule into a mixture of derivatives that absorbs wavelengths in the 
VIS spectrum (blue-green coloured solutions) [33]. In this work, an analogical approach was 
utilized not to increase the UV-VIS absorbance of BAs but rather their electrochemical 
activity. By using 0.1 mol L–1 HClO4 in acetonitrile, serving concurrently as a dehydrating 
agent and as the SE, a very well developed voltammetric signal of CA and CDCA is obtained 
at ca +1.2 V (vs. Ag/AgNO3) (Fig. 3B) in cyclic voltammetry (CV) on BDD, GC and Pt 
electrodes. Other common BAs in humans, such as DCA and LCA, or UDCA, that is often 
used in pharmaceutics, do not show similar electrochemical activity after being in contact 
with 0.1 mol L–1 HClO4 in acetonitrile (Fig. 4). Such extremely different behaviour of 
relatively similar molecules points to the crucial role of the axial 7α-hydroxyl group, which is 
present in the primary BAs, CA and CDCA. The secondary BAs, DCA and LCA, lack the 
hydroxyl group at C7 altogether. A stereoisomer of CDCA, UDCA, possesses the equatorial 
7β-hydroxyl group (as opposed to the axial 7α-hydroxyl of CDCA), which results in a very 
different spatial arrangement of these two seemingly closely similar BAs [73]. 
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Fig. 4 Cyclic voltammogram of (a) LCA, (b) DCA and (c) UDCA (c = 9×10–5 mol L–1) in 
0.1 mol L–1 HClO4 in acetonitrile. Supporting electrolyte in dashed line. Water content 
0.550 ± 0.002%. Ambient temperature 21 °C. Scan rate 50 mV s–1. Polished BDD electrode 
(Ageom = 7.07 mm
2). Voltammograms recorded 90 min after the solutions were prepared from 
respective stock solutions. 
In CA and CDCA, the axial 7α-hydroxyl group is in the antiperiplanar position to the 
axial 8β-proton, which renders the molecule particularly prone to dehydration. After 
dehydration, double bond is introduced into the steroid core of CA and CDCA. The resulting 
alkene is more prone to electrochemical oxidation by removal of an electron from the bonding 
π-orbital. This is supported by the CE-MS results shown in Fig. 5. In principle, CDCA (1) 
(m/z = 410.33; CDCA·NH4
+ adduct) is dehydrated by the strong acid (HClO4), likely yielding 
Δ7 alkene (2) (m/z = 392.32; CDCA–H2O·NH4
+ adduct), which is thermodynamically 
preferred to Δ6 alkene (Zaitsev rule). After a longer period (>3 h), a new signal was observed 
in CE-MS, which corresponds to the loss of another hydroxyl group (C3) and addition of the 
acetamide group (3). This is further supported by the migration behaviour of the compound 
(3), which indicates a positively charged species (protonation of the acetamide). This product 
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can be rationalized by Ritter reaction [74]. It starts with an attack of the Lewis basic nitrogen 
of the acetonitrile at a cationic species (presumably generated by protonation of the double 
bond), followed by hydrolysis of the iminium intermediate with the water that is present. 
Obviously, the acetamide is not primarily responsible for the increased voltammetric activity 
of the BAs, as it was detected after >3 h, long after maximum voltammetric activity was 
observed (~75 min) (Fig. 6).  
 
Fig. 5 (A) CE-MS electropherogram of solution containing CDCA (c = 9×10−4 mol L−1) 
in acetonitrile containing 0.1 mol L−1 HClO4 and 0.550 ± 0.002% H2O obtained after 4 h. 
Three selected ion traces are shown (m/z 392.32, 410.33, 416.32). Inset: In-time development 
of ratio between respective peaks. (B) The proposed reaction mechanism for CDCA 
dehydration. Reprinted with permission from [71]. 
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Fig. 6 In-time development of the first CV peak height of CDCA (c = 9×10–5 mol L–1) in 
0.1 mol L–1 HClO4 in acetonitrile. Supporting electrolyte in dashed line. Water content 
0.550 ± 0.002%. Ambient temperature 21 °C. Scan rate 50 mV s–1. Polished BDD electrode 
(Ageom = 7.07 mm
2). Reprinted with permission from [71]. 
The dehydration reaction, responsible for the formation of electrochemically active 
species, proceeds relatively slowly as apparent form Fig. 6. After placing the BA in contact 
with HClO4, the voltammetric signal of CDCA gradually increased, until it stabilized after 
approximately 75 min. Moreover, a very important factor that affects the feasibility of the 
dehydration reaction is the water content in the dehydrating solutions. Intrinsically, the water 
content, coming from the concentrated HClO4 stock solution and air humidity, is 
0.550 ± 0.002% (240 mmol L–1) as determined by Karl Fischer titration. The well-developed 
signal is only observed when the water content is kept to the minimum (0.550%), otherwise, 
no signal of the BA is obtained (Fig. 7). Obviously, excessive water content does not allow 
for the dehydration reaction of the BA to proceed fully.  
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Fig. 7 Linear sweep voltammograms of CDCA (c = 1×10–4 mol L–1); curves a, c) in 
0.1 mol L–1 HClO4 in acetonitrile. Supporting electrolyte in dashed lines (b, d). Water content 
(a, b) 0.550 ± 0.002%, (c, d) 10.0%; ambient temperature 21 °C. Scan rate 50 mV s–1. 
Polished BDD electrode (Ageom = 7.07 mm
2). Reprinted with permission from [72]. 
A similar process that is observed for the primary BAs is expected for cholesterol 
(Fig. 8). In contact with 0.1 mol L–1 HClO4 in acetonitrile it provides a very well-developed 
voltammetric signal at ca +1.5 V (vs. Ag/AgNO3) (Fig. 8), which is significantly less positive 
than previously reported (+1.8 V vs. Ag/AgCl [57]). This finding paved a road to novel 
methods of cholesterol determination [75], in which cholesterol was for the first time 
electrochemically determined in batch and liquid-flow systems in a mixed medium of 
acetonitrile-water, owing to the relatively low oxidation potential. Methods of cholesterol 
determination are being developed in a separate dissertation project at author’s home 
institution (L. Benešová). Moreover, based on this finding, a method for the determination of 
7-DHC, an important biomarker of Smith-Lemli-Opitz syndrome, has been developed [76]. 
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Therefore, methods of cholesterol and 7-DHC determination were not further pursued in this 
work, and it was focused solely on methods for primary BAs determination. 
 
Fig. 8 Cyclic voltammogram of cholesterol (c = 5×10–5 mol L–1) in 0.1 mol L–1 HClO4 in 
acetonitrile. Supporting electrolyte in dashed line. Water content 0.550 ± 0.002%. Ambient 
temperature 21 °C. Scan rate 50 mV s–1. Polished BDD electrode (Ageom = 7.07 mm
2). 
Voltammogram recorded 90 min after the solutions were prepared from respective stock 
solutions. 
3.2 Optimization of the chemical activation of CA and CDCA 
The current intensity of voltammetric response for activated CA and CDCA differs under 
ambient conditions, as apparent in Fig. 3B. This is problematic, as these two biomolecules are 
found together in the human body, and, under ambient conditions, it is virtually impossible to 
distinguish between them based on their oxidation potentials, which are very similar. 
Moreover, the response of activated BAs is not stable in time as apparent from Fig. 6. For 
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these reasons, steps were taken to ensure stable and equivalent molar response from both 
BAs. 
Increasing the reaction temperature for the BA and 0.1 mol L–1 HClO4 in acetonitrile 
results in a unified and stable voltammetric response of the BAs. This is presumably due to 
increased rate of the activation reaction. The current response rose exponentially with 
increasing temperature, and linearly with increasing time. When the reaction mixture was 
heated up to 50 °C for 5 minutes, the current response did not further rise and was stable with 
the relative standard deviation (RSD) of 2.9% over the course of 95 minutes. Longer heating 
time paradoxically leads to a loss of signal at +1.2 V (vs. Ag/AgNO3) in the case of CA 
(30 minutes heating) while a new signal appears at ca +0.67 V (vs. Ag/AgNO3) (Fig. 9A), 
allowing differentiation between CA and CDCA. This phenomenon is apparently caused by 
further dehydration of the activated CA at the axial 12α-hydroxyl group that is lacking in 
CDCA. Thus, in the case of CDCA, there was only a slight increment in the signal at +1.2 V 
(vs. Ag/AgNO3) after 30 minutes of heating, evidently because it could not be further 
dehydrated (Fig. 9B). Therefore, to ensure equal and stable response of both CA and CDCA, 





3 Results and Discussion   29 
 
Fig. 9 Cyclic voltammograms of (A) CA, and (B) CDCA (c = 5×10–5 mol L–1) in 0.1 mol L–1 
HClO4 in acetonitrile (water content 0.550 ± 0.002%). Yellow lines (a): heating 5 min / 50 °C; 
blue lines (b): heating 30 min / 50 °C; dotted lines (c) correspond to supporting electrolyte. 
Scan rate 50 mV s–1. Polished BDD electrode (Ageom = 7.07 mm
2). Reprinted with permission 
from [72]. 
Various dehydrating agents were investigated in this work, as strong acids different from 
HClO4 could prove more efficient. In addition to HClO4, experiments were carried out with 
H2SO4, H3PO4, and HCl (all 0.1 mol L
–1). Under ambient temperature (21 °C), only the 
presence of HClO4 enabled the electrochemical oxidation of the BAs by their activation. 
However, after implementing the heating step (50 °C for 5 min), a signal was observed with 
H2SO4, approximately of one third intensity compared to that seen for HClO4. Nevertheless, 
0.1 mol L–1 HClO4 in acetonitrile was used throughout this work as the dehydrating agent 
providing the highest current response, and as the SE at the same time. 
The unified response that is attained by implementing the heating protocol and using 
HClO4 as the dehydrating agent is illustrated in Fig. 10. Equimolar (90 µmol L
–1) solutions of 
CA and CDCA provided peaks of similar height in differential pulse voltammetry (DPV). 
Also, a mixture of CA and CDCA (both 45 µmol L–1, 90 µmol L–1 total primary BAs) leads to 
a peak at a similar potential and with similar height (RSD of all 3 peak heights is 0.6%). 
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Owing to the unified signal intensity, both BAs can be simultaneously determined as the total 
primary BA pool. 
 
 
Fig. 10 Differential pulse voltammograms of (a) CA, c = 9×10–5 µmol L–1; (b) CDCA, c = 
9×10–5 µmol L–1; and (c) mixture of both CA, c = 4.5×10–5 µmol L–1 and CDCA, c = 4.5×10–
5 µmol L–1 recorded under optimized conditions. Solutions were heated up to 50 °C for 5 
minutes before the measurements. Supporting electrolyte 0.1 µmol L–1 HClO4 in acetonitrile 
(water content 0.550 ± 0.002%) in dotted line. Polished BDD electrode (Ageom = 7.07 mm
2). 
Reprinted with permission from [72]. 
To assess the feasibility of transferring the procedure to liquid-flow systems (FIA or 
HPLC), the effect of increased water content and the pH dependency of the voltammetric 
signal was investigated. These parameters are highly important, especially in HPLC, because 
standard chromatographic columns are sensitive to extreme pH values. Adjusting the water 
content in HPLC allows for higher variability in polarity of the mobile phase used, thus for 
potentially increased separation efficiency. In FIA, the option to use mixed organic-aqueous 
phase results in a decrease in consumption of expensive and potentially toxic organic 
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solvents, especially in analyses conducted at large scale. It was shown that after the activation 
reaction proceeds (BA in contact with 0.1 mol L–1 HClO4 in acetonitrile at 50 °C for 5 min) 
both the water content and pH can be increased without losing the voltammetric signal. This 
allows for a wide range of pH (confirmed 1–13) and water content (confirmed up to 40%) 
adjustments according to the requirements of the subsequently employed liquid-flow 
technique. Throughout this work, there was no need to adjust neither the pH of the studied 
solutions, as the techniques used are robust enough to operate under highly acidic conditions, 
nor the water content simply because it would not add any benefit to the selectivity or 
sensitivity of the method. 
3.3 Basic characteristics of the electrochemical oxidation of CA 
and CDCA 
Understanding the nature of the reaction on which an analytical procedure is based on is 
beneficial for selecting the optimal parameters of such procedure. Thus, in Fig. 11, the 
mechanism of the electrochemical oxidation (steps two and three) of activated (step one) 
CDCA is proposed. A similar process is expected for CA. First, an electron is abstracted from 
the double bond of the activated CDCA (2) giving rise to a radical cationic species (4). This 
species is then approached by a water molecule, which, acting as a nucleophile, is added on 
the steroid core. After that, one more electron and two protons are abstracted from the 
intermediate, and a ketonic species (5) is formed. Overall, it is a two electron, two proton 
electrochemical process. Obviously, the likelihood of double bond migration is not negligible, 
therefore, further experiments are being conducted to confirm the exact position of the double 
bond, and the ketonic function, respectively. To evaluate the nature of the electrochemical 
process, linear sweep voltammograms with increasing scan rate (5–500 mV s–1) were 
recorded and evaluated. Slope of the log ip (in nA) vs. log v (in mV s
–1) dependencies was 
0.53 ± 0.01 for CA and 0.46 ± 0.02 for CDCA, respectively. This points to a diffusion-
controlled process, for which the theoretical slope value is 0.5. Therefore, attempts to 
preconcentrate the analytes on the electrode surface were of no avail. A complementary 
reduction peak was not observed in CV even at high scan rates up to 5 V s–1 when the scan 
was terminated right after the first peak. Therefore, the process can be considered irreversible 
under the conditions used. 
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Fig. 11 Proposed mechanism of chemical activation and subsequent electrochemical oxidation 
of CDCA. Reprinted with permission from [72]. 
3.4 Determination of activated CA and CDCA 
3.4.1 Differential pulse voltammetry 
 After the BAs are activated by 0.1 mol L–1 HClO4 in acetonitrile and their signal is 
stabilized and unified by implementing the heating protocol (50 °C for 5 min), they can be 
determined electrochemically by their oxidation. Considering the irreversibility of the BAs 
electrochemical oxidation process, DPV was employed as the batch quantitation technique. 
The following parameters were found to be optimal: step potential 5 mV; pulse time 5 ms; 
and pulse potential 100 mV. The selected scan rate of 50 mV s–1 is the maximal possible 
value of the instrument used in this study. To eliminate the negative effect of fouling, the 
electrode was polished using alumina/deionized water slurry between measurements. Neither 
anodic, nor cathodic activation of the BDD surface led to improved response. Calibration 
dependencies for CA and CDCA are summarized in Tab. 2 and shown in Fig. 12. The LODs 
are lower than/comparable to other studies that were aimed at low-cost platforms for BA 
determination [21,23,48–51]. Also, as apparent from the slope values in Tab. 2, the response 
3 Results and Discussion   33 
of both BAs is equivalent, which is beneficial for their simultaneous determination as the sum 
of the primary BAs. 
Tab. 2 Figure of merit for CA and CDCA determination in 0.1 M HClO4 in acetonitrile by 
DPV at polished BDD electrode. Reprinted with permission from [72]. 
Bile acid slope (nA L mm–2 
µmol–1) 
intercept (nA mm–2) r LOD (µmol–1) 
CA 5.54 ± 0.09  –2.97 ± 2.12  0.9991 0.5 
CDCA 5.58 ± 0.18 +2.68 ± 2.94  0.9962 1.0 
 
Fig. 12 Differential pulse voltammograms of CA (2, 4, 6, 8, 10, 20, 40, 60, and 80 µmol L–1) 
obtained under optimized conditions. Inset: Calibration dependencies of (a) CDCA, and (b) 
CA obtained using DPV (error bars represent SD). Each solution of the BA was heated up to 
50 °C for 5 minutes before the measurement. Supporting electrolyte: 0.1 mol L–1 HClO4 in 
acetonitrile in dotted line (water content 0.550 ± 0.002%). Polished BDD electrode (Ageom = 
7.07 mm2). Reprinted with permission from [72]. 
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 The most common matrix in which BAs are determined is blood serum. Therefore, 
experiments were conducted in artificial serum (prepared according to refs. [77,78]) to 
optimize the analytical procedure, and subsequently in human blood serum. Both were spiked 
with CA and CDCA to provide the total concentration of 20 µmol L–1. As mentioned before, 
excessive water content does not allow the dehydration reaction to proceed. For that reason, a 
simple solid-phase extraction on C18 cartridge, modified from ref. [51], had to be 
implemented in the procedure. After extraction, the BAs were determined by standard 
addition method using DPV and previously proposed HPLC-FLD used as a reference method 
[40]. 
 
Fig. 13 Differential pulse voltammograms of CA after extraction from (A) artificial serum, 
and (B) human serum obtained under optimized conditions. (a) Sample, (b) standard addition 
of c = 13.6 µmol L–1 CA, and (c) standard addition of c = 27.3 µmol L–1 CA, control extract 
with no spike in dotted line. Solutions were heated up to 50 °C for 5 minutes before the 
measurements. Supporting electrolyte 0.1 mol L–1 HClO4 in acetonitrile (water content 
0.550 ± 0.002%). Polished BDD electrode (Ageom = 7.07 mm
2). Insets: Standard addition 
dependency with the respective extrapolation used for quantitation of CA, error bars represent 
SD. Pearson's r > 0.9999 for both (A) and (B). Reprinted with permission from [72]. 
 The voltammetric response of CA extracted from artificial and human serum is shown in 
Fig. 13. It is apparent that after the extraction from both artificial (3.13A) and human (3.13B) 
serum sample a well-developed peak rising linearly with increasing concentration of the BA 
3 Results and Discussion   35 
was observed. Slightly poorer development of the peaks and a potential shift to more positive 
potentials in the case of human serum is naturally caused by its more complex nature. A 
similar response was attained with CDCA. The results obtained by both DPV and HPLC-FLD 
are summarized in Tab. 3. Student’s t-test was employed to determine whether there is a 
significant difference between these two methods. The null hypothesis was set to state that 
any discrepancies in the obtained results are purely due to random and not systematic errors. 
It is apparent from the p values that both in artificial serum and in human serum the results do 
not differ significantly (p > 0.05). The recoveries were slightly lower for CDCA compared to 
CA in artificial serum. This is most likely caused by lowered extraction efficiency of the SPE 
towards CDCA in artificial serum. In human serum, the recoveries for CA and CDCA were 
slightly lower compared to HPLC-FLD (82% and 80%, 89% and 88% respectively). This is 
presumably caused by passivation of the electrode by an electroactive compound, that is co-
extracted from human serum with the BAs, and is apparent as peak “X” in the recorded 
voltammograms (Fig. 13B). 
Tab. 3 Figure of merit for CA and CDCA determination in artificial and human serum by 
DPV. Uncertainty represents standard deviation (SD) for 5 repeated measurements. Reprinted 
with permission from [72]. 
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CA 20.0 19.0 ± 1.7 95 ± 8.7 19.0 ± 1.1 95 ± 5.5 0.90 
CDCA 20.0 14.6 ± 0.9 73 ± 4.7 15.8 ± 1.2 79 ± 6.0 0.29 
Human  
serum 
      
CA 20.0 16.3 ± 0.9 82 ± 4.5 17.8 ± 1.1 89 ± 5.5 0.22 
CDCA 20.0 15.9 ± 1.2 80 ± 6.0 17.5 ± 0.8 88 ± 4.1 0.28 
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Overall, the proposed voltammetric method can determine the BAs in both artificial and 
human serum providing results not significantly different from the HPLC-FLD method. 
Relatively high recoveries between 80% and 90% were consistently attained. The method 
proved to be selective for CA and CDCA even in a complex matrix such as human serum. 
However, determination of an individual primary BA (CA or CDCA), in the presence of the 
other one, is not possible under these conditions due to the similarity in their detection 
potentials. Only total primary BAs can be determined this way. In future works, steps ought to 
be taken to further optimize the extraction procedure to increase the extraction efficiency and 
eliminate (electrochemically active) interferents. 
3.4.2 Flow injection analysis with amperometric detection 
To assess the feasibility of transferring the voltammetric method to liquid-flow systems, 
pilot experiments in FIA-AD (amperometric detection) were performed using wall-jet 
detection cell with BDD electrode. Several parameters were optimized, such as detection 
potential (Edet = +1.8 V vs. Ag/AgCl), flow rate (3.5 ml min
–1) and injection volume 
(Vinj = 49 µL). After the chemical activation of CA and CDCA, their concentration 
dependencies were obtained (Fig. 14, Tab. 4). The LODs were estimated to be ca 1 µmol L–1, 
which is comparable to the LODs obtained in DPV (0.5 µmol L–1 for CA, 1.0 µmol L–1 for 
CDCA). It is apparent that both BAs show linear course of the concentration dependencies, 
however, their slopes differ. The culprit of this discrepancy is most likely a slight difference 
in the positioning of the electrode within the detection cell for the individual BAs. However, 
there is a major benefit of this approach compared to DPV, taking advantage of BDD’s low 
propensity to fouling. The working electrode in this experimental setup does not require 
mechanical polishing between individual scans, hence, when the method is fully transferred to 
a liquid-flow system, it will become significantly more user-friendly and cost-effective. 
However, the construction of the detection cell needs to be addressed so that a unified current 
response between measuring sessions is attained. Hopefully, these pilot results will lead to a 
full FIA/HPLC method applicable on real-life matrices in the future. 
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Tab. 4 Figure of merit for CA and CDCA determination. Measured by FIA-AD in 0.1 M 
HClO4 in acetonitrile. The following conditions were used: Edet = +1.8 V (vs. Ag/AgCl), flow 
rate: 3.5 ml min–1, injection volume (Vinj = 49 µL). 
Bile acid slope (nA L mm–2 
µmol–1) 
intercept (nA mm–2) r LOD (µmol L–1) 
CA 10.38 ± 0.13  –2.97 ± 2.12  0.9994 1 
CDCA 8.34 ± 0.40 +2.68 ± 2.94  0.9908 1 
 
 
Fig. 14 Concentration dependency of (a) CA and (b) CDCA obtained by FIA-AD. Run 
electrolyte 0.1 mol L–1 HClO4 in acetonitrile (water content 0.550±0.002%). Mobile phase 
0.1 mol L–1 HClO4 in acetonitrile (water content 0.550±0.002%). Boron doped diamond 
working electrode (Ageom = 7.07 mm
2), reference Ag/AgCl (3 mol L–1 KCl) electrode. 
Solutions were heated up to 50 °C for 5 minutes before the measurements. Each calibration 
point was measured 5 times, error bars represent SD. The following conditions were used: 
Edet = +1.8 V (vs. Ag/AgCl), flow rate: 3.5 ml min
–1, injection volume (Vinj = 49 µL). 
 
4 Conclusion   38 
4 Conclusion 
In this doctoral thesis, a novel electrochemical method for the determination of two major 
primary BAs in human, CA and CDCA, is proposed and characterized. The method consists 
of two steps: (i) chemical activation of the BAs to increase their susceptibility to 
electrochemical oxidation and (ii) quantitation of the activated BAs by their oxidation in 
voltammetry or amperometry. This approach is inspired by the Liebermann-Burchard reaction 
of cholesterol, which, by multiple dehydrations and other modifications of the steroid core, 
increases the VIS absorption properties of cholesterol and enables its colorimetric 
determination. In this work, instead of VIS absorption, the electrochemical activity of CA and 
CDCA is increased by a chemical reaction. The chemical activation is attained by dehydrating 
the BAs with a solution of HClO4 in acetonitrile so that it provides well-developed 
voltammetric response at ca +1.2 V (vs. Ag/AgNO3 in acetonitrile) in CV. 
The nature of the chemical activation process was investigated using CE-MS, and the 
results corroborate a loss of H2O of the parent BA molecule upon becoming electrochemically 
active. The mechanism of the electrochemical oxidation has been proposed, it consists of 
electrochemical abstraction of an electron from the double bond newly introduced to the 
structure of the BA by the chemical activation. Then, this newly formed radical cationic 
species is approached by a water molecule, acting as a nucleophile, which is added on the 
steroid core. The resulting intermediate is further oxidized to a ketonic species by losing an 
additional electron and two protons. Overall, this is a two electron two proton electrochemical 
process. Obviously, there is a possibility of double bond migration within the steroid core, 
therefore, the exact position of the resulting ketone cannot be stated with high certainty at this 
point. Moreover, a mixture of products can be also expected after the chemical activation. 
Experiments including NMR and cyclic IM-MS characterization of the product(s) of both the 
chemical activation and the electrochemical oxidation are underway, and the results will be 
duly published in a separate study. 
The chemical activation reaction is significantly affected by the water content in the 
dehydrating solution (should be kept as low as possible, 0.55% in this work), reaction 
temperature (if increased, the reaction proceeds with higher rate, heating at 50 °C for 5 
minutes was used in this work), and by the choice of the dehydrating agent (signal was 
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observed only with HClO4 and H2SO4; HCl and H3PO4 proved incapable to activate the BAs 
for electroanalysis). All these parameters must be strictly followed for the dehydration 
reaction to proceed fully. Nevertheless, once the dehydration reaction proceeds, the water 
content, as well as the pH of the solution, can be increased. This allows for greater variability 
of the solution parameters (polarity, pH) in liquid flow techniques, especially in HPLC.  
The method is applicable to primary bile acids, i.e., CA and CDCA. Other common BAs 
in humans, such as DCA or LCA, or a BA widely used in medical preparations, UDCA, 
cannot be activated in the same way. This highlights the importance of a structural feature 
present only in CA and CDCA amongst these BAs – the axial 7α hydroxyl group. Both DCA 
and LCA lack hydroxyl group at C7 altogether, and UDCA, a stereoisomer of CDCA, 
possesses the equatorial 7β hydroxyl group (for structures see Fig. 1). It is obvious that the 
axial 7α hydroxyl group renders the BA molecule especially prone to dehydration. For this 
reason, it is hypothesized that other BAs that possess the axial 7α hydroxyl group, natural or 
synthetic, should become electrochemically active under similar conditions. This would 
significantly widen the limited determination options for molecules such as α-muricholic acid, 
a major BA in mice, or various synthetic BAs that are candidate molecules for applications as 
medical drugs. All these possibilities should be further evaluated and pursued in follow-up 
studies conducted beyond the scope of this thesis. Moreover, similar positive effect on 
electrochemical activity was observed with related steroid compounds, cholesterol and 7-
DHC. Based on these findings, methods of their voltammetric and amperometric 
determination are being developed in separate diploma/dissertation projects at author’s home 
institution. 
The LODs of the newly developed DPV method for the CA and CDCA determination are 
0.5 mol L–1, and 1.0 mol L–1 respectively. In a pilot FIA-AD experiment, LODs of ca 
1 mol L–1 were obtained. These are competitive LOD values, especially when compared to 
biosensor platforms aimed at fast and low-cost determination of CA and CDCA. The LOD 
values of the newly developed method are comparable or lower than the ones of the currently 
existing methods [21,23,48–51]. Methods employing technically advanced equipment such as 
MS usually report notably lower LODs in the nanomolar range. On one hand, extremely low 
LODs can be viewed as unsubstantiated in clinical practice where, very often, CA and CDCA 
are of interest, and their levels usually range between tens to hundreds of micromoles per litre 
levels in patients with various diseases. On the other hand, in research applications, methods 
4 Conclusion   40 
combining a separation technique and MS detection can prove invaluable, as they allow for 
differentiation of several minor BAs and their derivatives present in the human body. This is 
something that is hardly achievable with simpler and more straightforward techniques, such as 
the one presented in this work. 
Overall, a simple and robust method for the electroanalytical determination of CA and 
CDCA was developed. This method allows simultaneous determination of both these BAs as 
the total primary BA pool. Moreover, with prolonged heating, it allows for their 
differentiation. It is applicable to both batch measurements (DPV), as well as liquid-flow 
techniques (FIA-AD). Owing to its competitive LODs, simplicity, and low time consumption, 
it has the potential to serve as a point of care technique in diagnosis of the number of diseases 
where CA or CDCA levels are of clinical importance. 
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